New Plain Language Labeling Rules Come Into Play For Non-Rx Drugs In Canada
Executive Summary
Sponsors of non-prescription drugs in Canada have until June 2021 to comply with new labeling obligations aimed at making it easier for patients and healthcare professionals to understand important information about the safe use of medicines.
You may also be interested in...
Canada Tilts At Unneeded Fixes In Self-Care Product Regulation Overhaul – Industry
Health Canada says its planned overhaul will not scrap the current natural health product framework, but industry is skeptical. In a Council for Responsible Nutrition webinar, an industry consultant says marketers of OTC drugs, supplements and cosmetics are discussing the proposal's negative implications with the agency.
'Plain language review' in store for all drug labels in Canada under new regs
Health Canada is seeking comments on its plans to implement new plain language labeling regulations for prescription drugs1.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.